Position in AZN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$348,521
New position
Shares Held
1,838
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#986
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudock, Inc. holds $16,088,795 across 11 Drug Manufacturers - General names. AZN ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
31,152 | $4,003,032 | |
| 2 | LLY |
ELI LILLY & Co
|
3,005 | $3,604,287 | |
| 3 | JNJ |
Johnson & Johnson
|
13,164 | $3,343,261 | |
| 4 | AMGN |
Amgen Inc
|
5,733 | $2,076,033 | |
| 5 | PFE |
Pfizer Inc
|
33,067 | $796,253 | |
| 6 | ABBV |
AbbVie Inc.
|
2,303 | $579,526 | |
| 7 | NVO |
Novo Nordisk A S
|
10,214 | $489,659 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,838 | $348,521 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,521 | 1,838 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||